HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Nutrition 21 Diachrome, Zeramax Sales To Be Backed By Research Initiatives

This article was originally published in The Tan Sheet

Executive Summary

Nutrition 21 plans to support the broad launch of its Diachrome chromium picolinate/biotin blend with a relatively large-scale clinical study, according to President and CEO Gail Montgomery

You may also be interested in...



Nutrition 21

Private placement to institutional and private investors including SF Capital Partners and P.A.W. Long Term Partners raises $3.25 mil., which firm plans to use for "continued clinical and market development of Diachrome," Nutrition 21 reports Oct. 14. Purchase, N.Y.-based company expects 600-person clinical study for the chromium and biotin combination product to be complete by June 30, 2004. Nutriton 21 will conduct a limited roll out of Diachrome until completion of the research (1"The Tan Sheet" Jan. 6, 2003, p. 13)...

Supply Side East In Brief

Cargill glucosamine: Regenasure non-shellfish, non-animal derived glucosamine hydrochloride will be commercially available in June after Cargill's new Eddyville, Iowa plant begins manufacturing product, company says at Supply Side East in Secaucus, N.J. May 6. Cargill has dedicated $10 mil.-$15 mil. to production of the premium-priced ingredient, according to the firm. Initial trade ad for Regenasure broke in April issue of Nutraceuticals World. Ingredient is expected to be available to consumers through both pill/capsule and beverage form by the end of 2003...

Experimental Biology 2003 In Brief

Caffeine/ephedra products: Individuals who consume caffeine/ephedra combinations increase their heart rate prior to, during and after exercise and raise their systolic blood pressure prior to exercise, placing "greater energy demands on [their] hearts," Katherine Kleinjan, et al., South Dakota State University, conclude. Researchers monitored ten "caffeine-naive" subjects administered 150 mg caffeine/20 mg ephedrine or placebo at 30 and 60 minutes after supplementation, at 10, 30 and 60 minutes after beginning cycling and after 15, 45 and 60 minutes of recovery for heart rate and blood pressure...

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS129272

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel